Skip to main content

Table 3 Patient characteristics, cohort 2 (bone marrow samples)

From: CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression

Characteristic

n = 36

Median age, years (range)

71 (52–92)

Gender

 

 Male

29% (11)

 Female

69% (25)

Myeloma type

n = 33

 IgG

51% (17)

 IgA

3% (1)

 Light chain only

 

  Kappa

36% (12)

  Lambda

9% (3)

%MM cells in BM, range

40% (5–95%)

Bone lesions

22 (61%)

Number of previous therapies (range)

2.5 (1–3)

  1. MM, multiple myeloma; BM, bone marrow; IgG, immunoglobulin G; IgA, immunoglobulin A